Citigroup Inc Geron Corp Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Geron Corp stock. As of the latest transaction made, Citigroup Inc holds 433,547 shares of GERN stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

433,547

Previous 229,020 89.31%

Holding current value

$1.76 Million

Previous $971,000 102.68%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.17 - $4.99 $852,877 - $1.02 Million	204,527 Added 89.31%	433,547 $1.97 Million
Q2 2024 Aug 12, 2024	SELL	$3.1 - $5.09 $5.96 Million - $9.78 Million	-1,921,951 Reduced 89.35%	229,020 $971,000
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $2.52 Million - $4.95 Million	1,439,022 Added 202.12%	2,150,971 $7.1 Million
Q4 2023 Feb 09, 2024	SELL	$1.74 - $2.31 $163,493 - $217,052	-93,962 Reduced 11.66%	711,949 $1.5 Million
Q3 2023 Nov 09, 2023	BUY	$2.11 - $3.28 $583,566 - $907,156	276,572 Added 52.25%	805,911 $1.71 Million
Q2 2023 Aug 10, 2023	SELL	$1.97 - $3.69 $1.87 Million - $3.51 Million	-951,365 Reduced 64.25%	529,339 $1.7 Million
Q1 2023 May 11, 2023	BUY	$2.14 - $3.4 $1.95 Million - $3.1 Million	910,697 Added 159.77%	1,480,704 $3.21 Million
Q4 2022 Feb 09, 2023	BUY	$2.03 - $2.42 $109,211 - $130,193	53,799 Added 10.42%	570,007 $1.38 Million
Q3 2022 Nov 10, 2022	BUY	$1.67 - $2.94 $226,869 - $399,399	135,850 Added 35.72%	516,208 $1.21 Million
Q2 2022 Aug 10, 2022	BUY	$1.19 - $1.65 $261,281 - $362,280	219,564 Added 136.55%	380,358 $590,000
Q1 2022 May 12, 2022	SELL	$0.99 - $1.6 $353,770 - $571,750	-357,344 Reduced 68.97%	160,794 $219,000
Q4 2021 Feb 10, 2022	BUY	$1.22 - $1.72 $269,541 - $380,009	220,936 Added 74.34%	518,138 $632,000
Q3 2021 Nov 10, 2021	BUY	$1.2 - $1.5 $356,642 - $445,803	297,202 New	297,202 $407,000

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.54B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account